Sector consensus Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.80 EUR | -1.30% |
|
-1.30% | -10.27% |
| 05-13 | Spanish stocks - Factors to watch on May 13 | RE |
| 05-09 | Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 1,240.46 | +2.03% | 28 | |||||||
| 258.59 | -1.83% | 22 | |||||||
| 258.32 | +2.21% | 28 | |||||||
| 359.22 | +7.26% | 18 | |||||||
| 217.01 | +14.04% | 22 | |||||||
| 153.92 | -1% | 21 | |||||||
| 316.91 | -1.93% | 24 | |||||||
| 354.97 | -3.54% | 29 | |||||||
| 158.3 | +16.55% | 27 | |||||||
| 28.93 | +20.28% | 27 | |||||||
| 554.28 | +11.21% | 25 | |||||||
| 63 | +9.49% | 24 | |||||||
| 21.14 | +6.81% | 19 | |||||||
| 96.31 | +27.79% | 23 | |||||||
| 10,006.67 | +36.24% | 15 | |||||||
| 53.69 | +8.17% | 18 | |||||||
| 6,106.87 | +12.03% | 15 | |||||||
| 81.21 | +50.37% | 15 | |||||||
| 437.5 | +35.24% | 24 | |||||||
| Average | 1,093.02 | +13.23% | 22 | ||||||
| Weighted average by Cap. | 707.53 | +5.92% | 24 |
Select your edition
All financial news and data tailored to specific country editions
















